Life Sciences

FDA reopens comment period for hemostatic devices

Device Regulation Alert: Safety, Compliance and Reimbursement News, September 22, 2008

For the second time, the FDA is reopening the comment period on its proposed guidance concerning reclassification of absorbable hemostatic devices. The public has until October 14 to comment.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   
    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Complete Guide to Lab Safety, 3rd Ed.

    The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...

Most Popular